Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization

Teruhiko Imamura1, Koichiro Kinugawa, Daisuke Nitta

  • 1Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo.

Insights

Complete left bundle branch block (CLBBB) and smaller left atrial volume index (LAVI) predict response to cardiac resynchronization therapy with defibrillator (CRT-D) in advanced heart failure patients. These responders may benefit more from CRT-D.

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Electrophysiology

Background:

  • Cardiac resynchronization therapy with defibrillator (CRT-D) is often considered, but its efficacy as a rescue strategy in advanced heart failure (HF), particularly in inotrope-dependent patients, remains uncertain.
  • Early ventricular assist device (VAD) implantation is suggested as an alternative, but predictors for CRT response in this population are not well-defined.

Purpose of the Study:

  • To identify predictors of response to CRT-D in patients with advanced heart failure.
  • To evaluate the impact of these predictors on clinical outcomes and VAD-free survival.

Main Methods:

  • Retrospective analysis of 67 advanced HF patients (<65 years) who received CRT-D between 2007 and 2014.
  • Logistic regression analysis to identify baseline predictors of CRT-D response, defined as >10% improvement in left ventricular ejection fraction (LVEF) at 6 months.
  • Comparison of clinical outcomes, including VAD-free survival, between responders and non-responders.

Main Results:

  • 16% of patients (11/67) were responders.
  • Complete left bundle branch block (CLBBB) and left atrial volume index (LAVI) <43 ml/m² were significant predictors of CRT-D response (OR 6.663, P=0.032 and OR 36.67, P=0.001, respectively).
  • Responders showed improved LVEF, reduced B-type natriuretic peptide, and higher 2-year VAD-free survival (86% vs. 52%, P=0.044) compared to non-responders.

Conclusions:

  • CLBBB and smaller LAVI are novel predictors of CRT-D response in advanced HF patients in real-world settings.
  • Patients with these predictors may be better candidates for CRT-D, potentially delaying the need for cardiac replacement therapy.
  • These findings aid in patient selection for CRT-D in advanced HF.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
583
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
545
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
769
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K